What a week for the major indexes! The S&P 500 and Dow both ended at record highs. The success of the broader markets paled in comparison to a handful of health-care stocks, though.
One of this week's soaring stocks received good news from across the Atlantic Ocean. Another saw shares advance in anticipation of upcoming clinical study results. And the third of the big winners also benefited from investor eagerness over a pending decision by the Food and Drug Administration.
Which health-care stocks soared stupendously this week? Find out by watching the following slideshow.
Keith Speights owns shares of Celgene. The Motley Fool recommends Celgene. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.